share_log

Cambridge Investment Research Advisors Inc. Boosts Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Defense World ·  Sep 24, 2022 05:01

Cambridge Investment Research Advisors Inc. increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Rating) by 4.5% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 37,663 shares of the medical equipment provider's stock after buying an additional 1,619 shares during the period. Cambridge Investment Research Advisors Inc.'s holdings in Intuitive Surgical were worth $7,559,000 as of its most recent SEC filing.

Several other institutional investors also recently added to or reduced their stakes in ISRG. Standard Family Office LLC purchased a new position in Intuitive Surgical during the 4th quarter valued at about $27,000. IronBridge Private Wealth LLC increased its position in Intuitive Surgical by 200.0% during the 4th quarter. IronBridge Private Wealth LLC now owns 81 shares of the medical equipment provider's stock valued at $29,000 after purchasing an additional 54 shares during the period. Comprehensive Financial Consultants Institutional Inc. purchased a new position in Intuitive Surgical during the 4th quarter valued at about $30,000. JFS Wealth Advisors LLC increased its position in Intuitive Surgical by 145.2% during the 1st quarter. JFS Wealth Advisors LLC now owns 103 shares of the medical equipment provider's stock valued at $31,000 after purchasing an additional 61 shares during the period. Finally, Vectors Research Management LLC increased its position in Intuitive Surgical by 200.0% during the 4th quarter. Vectors Research Management LLC now owns 90 shares of the medical equipment provider's stock valued at $32,000 after purchasing an additional 60 shares during the period. Hedge funds and other institutional investors own 82.44% of the company's stock.

Get Intuitive Surgical alerts:

Analyst Upgrades and Downgrades

ISRG has been the topic of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft lowered their price target on shares of Intuitive Surgical from $225.00 to $205.00 in a report on Friday, July 22nd. BTIG Research lowered their target price on shares of Intuitive Surgical from $355.00 to $247.00 and set a "buy" rating for the company in a research note on Monday, July 18th. Piper Sandler lifted their target price on shares of Intuitive Surgical from $255.00 to $260.00 and gave the stock an "overweight" rating in a research note on Thursday, August 18th. The Goldman Sachs Group decreased their price objective on shares of Intuitive Surgical from $319.00 to $273.00 and set a "buy" rating for the company in a research note on Friday, July 29th. Finally, Morgan Stanley decreased their price objective on shares of Intuitive Surgical from $300.00 to $225.00 and set an "equal weight" rating for the company in a research note on Friday, July 15th. Six research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. According to MarketBeat, Intuitive Surgical presently has an average rating of "Moderate Buy" and a consensus target price of $268.00.

Intuitive Surgical Trading Down 0.3 %

ISRG stock opened at $190.52 on Friday. The business has a 50 day simple moving average of $218.90 and a 200-day simple moving average of $233.18. Intuitive Surgical, Inc. has a twelve month low of $186.83 and a twelve month high of $369.69. The company has a market capitalization of $68.04 billion, a P/E ratio of 48.48, a PEG ratio of 5.43 and a beta of 1.31.

Intuitive Surgical (NASDAQ:ISRG – Get Rating) last issued its quarterly earnings results on Thursday, July 21st. The medical equipment provider reported $0.85 earnings per share for the quarter, missing the consensus estimate of $1.04 by ($0.19). Intuitive Surgical had a return on equity of 12.04% and a net margin of 24.05%. The company had revenue of $1.52 billion for the quarter, compared to analyst estimates of $1.56 billion. During the same period in the prior year, the business earned $1.42 earnings per share. Research analysts predict that Intuitive Surgical, Inc. will post 3.76 EPS for the current fiscal year.

Insider Buying and Selling

In related news, Director Amal M. Johnson sold 6,375 shares of the stock in a transaction on Wednesday, August 3rd. The stock was sold at an average price of $238.04, for a total transaction of $1,517,505.00. Following the completion of the sale, the director now directly owns 11,224 shares of the company's stock, valued at $2,671,760.96. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In related news, Director Amal M. Johnson sold 6,375 shares of the stock in a transaction on Wednesday, August 3rd. The stock was sold at an average price of $238.04, for a total transaction of $1,517,505.00. Following the completion of the sale, the director now directly owns 11,224 shares of the company's stock, valued at $2,671,760.96. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Myriam Curet sold 9,000 shares of the stock in a transaction on Wednesday, July 27th. The stock was sold at an average price of $225.00, for a total value of $2,025,000.00. Following the completion of the transaction, the executive vice president now owns 217 shares of the company's stock, valued at approximately $48,825. The disclosure for this sale can be found here. Insiders sold a total of 101,162 shares of company stock valued at $22,062,916 over the last three months. 0.90% of the stock is currently owned by company insiders.

About Intuitive Surgical

(Get Rating)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Recommended Stories

  • Get a free copy of the StockNews.com research report on Intuitive Surgical (ISRG)
  • MarketBeat: Week in Review 9/19 – 9/23
  • Why Does Tesla Stock Remain Resilient?
  • Is Costco's Post-Earnings Price Weakness A Good Time To Buy?
  • Are Layoffs At A Small-Cap Tech A Bellwether For Housing Stocks?
  • 2 Semiconductor Stocks To Watch For Reversals

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment